Related Experiment Videos
Pathological aspects of beta(2)-microglobulin amyloidosis
M Jadoul1, C Garbar, C van Ypersele de Strihou
1Department of Nephrology, Cliniques Universitaires St. Luc, Université Catholique de Louvain, Brussels, Belgium. jadoul@nefr.ucl.ac.be
Seminars in Dialysis
|March 27, 2001
Summary
Beta-2 microglobulin amyloidosis (A beta(2)M) is diagnosed via histology, Congo red staining, and immunostaining. Early joint deposits occur before symptoms, with inflammation potentially driving clinical manifestations.
Area of Science:
- Nephrology
- Pathology
- Rheumatology
Background:
- Beta-2 microglobulin amyloidosis (A beta(2)M) is a complication of long-term dialysis.
- Histological diagnosis is the gold standard, requiring Congo red staining and anti-beta(2)M immunostaining.
- A beta(2)M amyloid deposits preferentially affect joints but can involve other organs like the heart and GI tract.
Purpose of the Study:
- To describe the diagnostic criteria for A beta(2)M.
- To outline the pathological stages of A beta(2)M formation.
- To discuss potential factors involved in A beta(2)M precipitation.
Main Methods:
- Histological examination of amyloid deposits.
- Congo red staining and polarized light microscopy.
- Immunostaining with anti-beta(2)M antibodies.
Main Results:
- A beta(2)M amyloidosis is diagnosed by characteristic histological findings.
- Early articular A beta(2)M deposition is common in dialysis patients, preceding clinical symptoms.
- Three pathological stages of A beta(2)M amyloid formation have been identified, with macrophage recruitment occurring in later stages.
Conclusions:
- Histology is crucial for diagnosing A beta(2)M.
- Articular A beta(2)M deposits precede clinical symptoms in dialysis patients.
- The exact triggers for beta(2)M fibrillar precipitation remain unknown, though several substances are implicated.